Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
SLNO Soleno Therapeutics
- 45.1800
- -0.0200-0.04%
Close Dec 20 16:00 ET
- 45.1800
- 0.00000.00%
Post 20:01 ET
1.95BMarket Cap-16.19P/E (TTM)
46.5700High44.1900Low1.28MVolume44.7500Open45.2000Pre Close58.11MTurnover4.60%Turnover RatioLossP/E (Static)43.12MShares60.920052wk High7.36P/B1.26BFloat Cap35.700052wk Low--Dividend TTM27.90MShs Float742.5000Historical High--Div YieldTTM5.27%Amplitude0.8500Historical Low45.3010Avg Price1Lot Size
About Soleno Therapeutics Company
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Company Profile
SymbolSLNO
Company NameSoleno Therapeutics
Listing DateNov 13, 2014
Founded1999
CEODr. Anish Bhatnagar, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address100 Marine Parkway,Suite 400
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-213-8444
Websitehttp://www.soleno.life
Company Executives
- Name
- Position
- Salary
- Dr. Anish Bhatnagar, M.D.
- President, Chief Executive Officer, Chief Operating Officer and Director
- 4.12M
- James H. Mackaness
- Chief Financial Officer and Principal Accounting Officer
- 1.21M
- Meredith S. Manning
- Chief Commercial Officer
- --
- Dr. Michael Huang, M.D.
- Senior Vice President, Clinical Development
- --
- Patricia C. Hirano
- Senior Vice President, Regulatory Affairs
- 1.03M
- Kristen Yen
- Senior Vice President, Clinical Operations
- --
- Dawn Carter Bir
- Director
- --
- Matthew Pauls, J.D.,M.B.A.
- Lead Independent Director
- 70.53K
- William G. Harris
- Independent Director
- 111.87K
- Dr. Birgitte Volck, M.D.,PhD
- Independent Director
- 102.87K
- Dr. Andrew Sinclair, PhD
- Independent Director
- 51.87K